TaskUs Stock (NASDAQ:TASK), Trade Ideas

TaskUs

TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to inventive and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADIL

AGFY

AMRN

ARRY

AUMN

BBWI

BCAN

BEDU

BFLY

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLUE

CMPS

COMM

CRML

CSTL

CTKB

DAVA

DUOL

ENVB

ESTA

FIGS

GRFS

GYRE

HAYW

IHRT

INDP

INSG

IONQ

IRWD

LPSN

MGNI

MIST

MRSN

NARI

NTES

NWTN

OCEA

OKTA

ORIC

PSTG

PZZA

QURE

RNLX

RVNC

SCTL

SDGR

SHLS

SIDU

SNOW

STER

STKL

SWIM

TASK

VERX

VLCN

XMTR

Shares of  Butterfly Network, Inc.  (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.

Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John&#39;s International And Other Big Stocks Moving Higher On Thursday

ADTN

ALPN

ALTO

AMRC

ATSG

AUGX

AURA

CHRS

CLOV

CNHI

DCGO

DDOG

EVCM

EVER

FGEN

Hims & Hers Health, Inc. Class A Common Stock

HIMS

ICUI

JWEL

LIFW

MGNX

MYGN

NINE

OLPX

OMIC

OPRT

OSCR

PLNT

PRAA

PXMD

RMCO

ROVR

SAGE

SANM

SGRY

SNTI

STRL

TCMD

TDUP

THAR

TMDX

TRIP

TWKS

VMEO

VTYX

WLDS

WWAC

Gainers


	PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.


Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

TaskUs Inc

WIIM

Bank OZK shares are trading higher following better-than-expected Q1 earnings.

BHVN

Biohaven shares are trading lower after the company priced a 5.609 million share offering at $41 per share.

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and raises the price target from $1.5 to $1.6.

Price Target

Analyst Ratings

HC Wainwright & Co. Maintains Buy on Avino Silver & Gold Mines, Raises Price Target to $1.6

Zscaler shares are trading higher after KeyBanc upgraded the stock from Sector Weight to Overweight.

Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) reported quarterly earnings of $4.75 per share which beat the analyst consensus estimate of $4.64 by 2.37 percent. The company reported quarterly sales of $1.182 billion which missed the analyst consensus estimate of $1.199 billion by 1.43 percent. This is a 0.08 percent decrease over sales of $1.183 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Snap-on Q1 2024 Adj EPS $4.75 Beats $4.64 Estimate, Sales $1.182B Miss $1.199B Estimate

General

Mirion Will Redeem All Of Its Publicly Traded Warrants To Purchase Shares Of Class A Common Stock, For A Redemption Price Of $0.10 Per Warrant

Nokia shares are trading higher after the company reported Q1 financial results.

Taiwan Semiconductor shares are trading lower following Q1 earnings.

RCAT

Red Cat Announces Partnership With Sentien Robotics Enabling Organizations Using Sentien's Hive UAS Management Platforms To Deploy Teal Drones As Part Of A Larger Autonomous Drone Swarming Strategy For Mobile And Fixed-position Land, Air, And Sea Defense And Security Operations.

Biotech

Health Care

CERE

Cerevel Therapeutics' Topline Results From Phase 3 TEMPO-3 Trial For Tavapadon For Parkinson's Disease, Met Primary Endpoint, Demonstrating Statistically Significant Increase In Total "On" Time Without Troublesome Dyskinesia Vs. Placebo

HC Wainwright &amp; Co. analyst Robert Burns reiterates IGM Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) with a Neutral and maintains $12 price target.

Reiteration

IGMS

HC Wainwright & Co. Reiterates Neutral on IGM Biosciences, Maintains $12 Price Target

KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) reported quarterly sales of $1.53 billion which beat the analyst consensus estimate of $1.51 billion by 1.52 percent. This is a 10.56 percent decrease over sales of $1.71 billion the same period last year.

KeyCorp Q1 Sales $1.53B Beat $1.51B Estimate

Guidance

D.R. Horton Sees 2024 Consolidated Revenues $36.7B-$37.7B vs $36.32B Est., Homes Closed By Homebuilding Operations 89K-91K

D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) reported quarterly earnings of $3.52 per share which beat the analyst consensus estimate of $3.07 by 14.66 percent. The company reported quarterly sales of $9.100 billion which beat the analyst consensus estimate of $8.266 billion by 10.09 percent. This is a 14.14 percent increase over sales of $7.973 billion the same period last year.

D.R. Horton Q2 2024 GAAP EPS $3.52 Beats $3.07 Estimate, Sales $9.100B Beat $8.266B Estimate

Canaccord Genuity analyst Maria Ripps maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and raises the price target from $580 to $610.

Canaccord Genuity Maintains Buy on Meta Platforms, Raises Price Target to $610

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Beam Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEEM#NASDAQ">BEEM</a>) with a Buy and maintains $30 price target.

BEEM

HC Wainwright & Co. Reiterates Buy on Beam Glb, Maintains $30 Price Target

Shares of Alcoa Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aa#NYSE">AA</a>) rose sharply in today&rsquo;s pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/quote/AA/earnings">sales for its first quarter</a>.
The company reported quarterly losses of 81 cents per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Alcoa still sees full-year alumina production of between 9.8 million and 10 million metric tons and full-year alumina shipments between 12.7 million and 12.9 million metric tons.
Alcoa shares jumped 3% to $36.60 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Tian Ruixiang Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tirx#NASDAQ">TIRX</a>) shares gained 155.6% to $1.24 in pre-market trading after gaining around 8% on Wednesday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) gained 51.8% to $3.40 in pre-market trading after falling around 5% on Wednesday.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) shares gained 28.4% to $0.6035 in pre-market trading after gaining over 21% on Wednesday.</li>
<li>Tantech Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tanh#NASDAQ">TANH</a>) gained 19.6% to $0.88 in pre-market trading.</li>
<li>Zapp Electric Vehicles Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zapp#NASDAQ">ZAPP</a>) shares rose 19.3% to $0.20 in pre-market trading after tumbling 35% on Wednesday.</li>
<li>ReTo Eco-Solutions Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) rose 19% to $1.13 in today&rsquo;s pre-market trading after tumbling 25% on Wednesday.</li>
<li>Acurx Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acxp#NASDAQ">ACXP</a>) gained 10.6% to $1.99 in pre-market trading after gaining over 8% on Wednesday.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) shares gained 10.4% to $0.0488 in pre-market trading.</li>
<li>Tenax Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenx#NASDAQ">TENX</a>) shares gained 9.3% to $3.98 in pre-market trading.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Planet Green Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plag#NYSE">PLAG</a>) fell 20.6% to $0.16 in pre-market trading after dipping 10% on Wednesday.</li>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) fell 19.8% to $0.4090 in pre-market trading after gaining 8% on Wednesday.</li>
<li>NRx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrxp#NASDAQ">NRXP</a>) fell 19.4% to $3.36 in pre-market trading. NRx Pharmaceuticals announced a proposed underwritten public offering of common stock.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) fell 17.8% to $1.29 in pre-market trading.</li>
<li>Trio Petroleum Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpet#NASDAQ">TPET</a>) declined 17% to $0.2821 in pre-market trading. Trio Petroleum shares dipped 30% on Wednesday after the company announced it entered into a securities purchase agreement with an institutional investor in the amount of $360,000..</li>
<li>ICZOOM Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izm#NASDAQ">IZM</a>) shares fell 15.6% to $5.05 in pre-market trading after tumbling 88% on Wednesday. ICZOOM announced cancellation of proposed public offering.</li>
<li>Arrowroot Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aile#NASDAQ">AILE</a>) fell 15% to $8.50 pre-market trading after dipping 42% on Wednesday.</li>
<li>SeaStar Medical Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icu#NASDAQ">ICU</a>) shares fell 14.2% to $0.60 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) fell 13.3% to $0.6762 pre-market trading. Spectaire recently announced that it signed a distribution partnership agreement with a Fortune 1000 Energy Company.</li>
<li>Flora Growth Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgc#NASDAQ">FLGC</a>) shares declined 10.5% to $1.60 in pre-market trading.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38307448/investor-sentiment-decreases-further-s-p-500-falls-for-fourth-straight-session"> Investor Sentiment Decreases Further, S&amp;P 500 Falls For Fourth Straight Session</a>

Pre-Market Outlook

ACXP

AILE

BRSH

FLGC

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

NRXP

PLAG

RETO

SELX

SMFL

SNGX

SPEC

TANH

TENX

TIRX

TPET

ZAPP

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Barclays analyst Christine Cho maintains Cheniere Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CQP#NYSE">CQP</a>) with a Underweight and lowers the price target from $51 to $45.

Barclays Maintains Underweight on Cheniere Energy Partners, Lowers Price Target to $45

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) with a Buy and maintains $54 price target.

URGN

HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $54 Price Target

<a href="https://pubmatic.com/">PubMatic</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>), an independent technology company delivering digital advertising&#39;s supply chain of the future, has today announced a partnership with Virgin Media, one of the UK&#39;s premier entertainment and communications companies, to enable advertisers to reach UK audiences at scale through premium ad-funded TV content.

PUBM

Virgin Media Partners Wwith PubMatic To Scale FAST Advertising In The UK

Analysts have been eager to weigh in on the Technology sector with new ratings on Clearwater Analytics Holdings (CWAN – Research Report), TaskUs (T...

Analysts Offer Insights on Technology Companies: Clearwater Analytics Holdings (CWAN), TaskUs (TASK) and C3ai (AI)

TaskUs (TASK – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst James Faucette from Morgan St...

Maintaining Hold: TaskUs's Strategic Shift Toward Smaller Accounts with Modest Revenue Growth Outlook

In a report released yesterday, Matthew VanVliet from BTIG maintained a Buy rating on TaskUs (TASK – Research Report), with a price target of $18.0...

Buy Rating Affirmed for TaskUs on Strong Q4 Performance and Promising 2024 Outlook

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Hold rating on TaskUs (TASK – Research Report), with a price target of ...

RBC Capital Sticks to Their Hold Rating for TaskUs (TASK)

TaskUs (TASK – Research Report), the Technology sector company, was revisited by a Wall Street analyst on February 28. Analyst David Koning from Ro...

Buy Rating for TaskUs: Strong Q4 Performance and High Profit Margins Signal Growth Amidst Industry Challenges

TaskUs: Digital Experiences, AI Services To Drive Revenue Growth